ライフサイエンスコーパス: echogenicity

1 and ultrasound assessment of Rectus Femoris echogenicity.

2 of the plaque, which was normalized to lumen echogenicity.

3 C concentrations that is necessary for blood echogenicity.

4 e mass contained a central area of increased echogenicity.

5 pered by the absence of a means of measuring echogenicity.

6 , genital malformation, and increased kidney echogenicity.

7 ures that cause measurable changes in tissue echogenicity.

8 74 [41.9%]), composition (23 of 74 [31.1%]), echogenicity (17 of 74 [23.0%]), margin (6 of 74 [8.1%])

9 Similarly, reporting of echogenicity (34 of 36 [94.4%]), shape (28 of 36 [77.8%]

10 aracterise the changes in macroscopic muscle echogenicity and fascial characteristics that occur earl

11 rse correlation between normalized LP plaque echogenicity and gray-scale median score.

12 xcept for shape in the first reading and for echogenicity and margins in the second reading, which ha

13 afting reduced the pathological increases of echogenicity and neointima formation in rats.

14 The aim of this work was to assess the echogenicity and the size of perirenal haematomas in pat

15 ney cross-sections and enabled measuring the echogenicity and thickness of the abnormalities at the s

16 Initial US echogenicity and vascularization influence the ablation

17 nts (thickness, width, cross-sectional area, echogenicity) and 3.0-T MR imaging measurements (thickne

18 Quadriceps muscle size, echogenicity, and fat thickness were measured using ultr

19 hic images with regard to origin, insertion, echogenicity, and location.

20 of propagation speed, attenuation, relative echogenicity, and mass density are reported for all tiss

21 ups differed regarding bowel wall thickness, echogenicity, and perfusion in sonograhy and color Doppl

22 US parameters were renal length, relative echogenicity, and resistive index (RI).

23 nearly perfect concordance for composition, echogenicity, and shape and substantial concordance for

24 sis of parameters such as x-ray attenuation, echogenicity, and sound attenuation.

25 echogenicity, but visual measures of B-mode echogenicity are negatively affected by interobserver va

26 Echogenicity at the site of the pathologic finding in th

27 rdiography demonstrated increased intramural echogenicity at the targeted region of the 3-dimensional

28 t of nonviable tumor determined as decreased echogenicity at ultrasonography (US) and lack of enhance

29 After cryoablation, there was increased echogenicity at US and increased density at mammography;

30 itatively associated with enhanced B-mode US echogenicity, but visual measures of B-mode echogenicity

31 US images were graded to determine echogenicity changes, CT attenuation was measured (in Ho

32 Lesion echogenicity (class I to IV), degree of stenosis, and ma

33 Correlation of neovascularization with echogenicity, degree of stenosis, and maximal lesion thi

34 c, "eyeglass" shape), grade II (intermediate echogenicity, "dumbbell" outline), and grade III (hypere

35 Lesions smaller than 6 mm with no punctate echogenicities had a minimal risk for malignancy.

36 n to the chest wall, border characteristics, echogenicity, homogeneity, enhancement or shadowing, and

37 Each tumor was evaluated for size, location, echogenicity, homogeneity, shadowing, hypoechoic rim, an

38 Only the presence of punctate echogenicities in the lesion (28 of 61 malignant lesions

39 hyperplasia, which correlated with the high echogenicity in HFU images and the large mechanical stre

40 IRE ablation produced greater alterations to echogenicity in normal tissues than in tumors.

41 r lesion shape (kappa=0.14), substantial for echogenicity (kappa=0.61), and moderate for posterior fe

42 s of the nodules were analysed (composition, echogenicity, margin, calcification status, the presence

43 onths to years and the pattern of lymph node echogenicity may suggest the diagnosis of ALPS.

44 = 4) on CT scans; and homogeneous, moderate echogenicity (n = 3) on US scans.

45 The echogenicity of lipomas ranged from hypoechoic to hypere

46 supported only one hypothesis: The apparent echogenicity of nanobubbles under both linear and nonlin

47 statistically significant, difference in the echogenicity of perirenal haematomas compared to the rou

48 Raw linear data were used to quantify echogenicity of the plaque, which was normalized to lume

49 If the vascularity and echogenicity of the scrotal mass is similar with the nor

50 e small intestine loops, and increase in the echogenicity of the surrounding mesenteric fat tissue.

51 sented hypoechogenic thrombus, whereas mixed echogenicity of thrombus appeared on 11 patients.

52 re visualized intraprocedurally as increased echogenicity on intracardiac echocardiography and incorp

53 c resonance imaging, 92% had increased liver echogenicity on ultrasonography, and 65% had splenomegal

54 common imaging finding was increased hepatic echogenicity on ultrasound in 39% (9) of patients, follo

55 LT) or moderate and severe increase in liver echogenicity on ultrasound.

56 reased attenuation on CT scans and increased echogenicity on US scans of renal adenomatous tumors are

57 of the following: persistent periventricular echogenicity or echolucency on neuroimaging, chronic lun

58 No change in echogenicity or fat thickness was observed.

59 fibrin-targeted contrast exhibited increased echogenicity (P < .05); control thrombi remained acousti

60 r platelet count (P = 0.007); abnormal liver echogenicity (P < 0.001); and splenomegaly (P = 0.001) a

61 tion using a high-frequency ultrasonic (HFU) echogenicity platform and estimated the endothelium yiel

62 Sonographic echogenicity ranged from hypoechoic to hyperechoic relat

63 under receiver operator curve for ultrasound echogenicity's prediction of myofiber necrosis was 0.74

64 nearly perfect concordance for composition, echogenicity, shape, and margins and substantial concord

65 nearly perfect concordance for composition, echogenicity, shape, and margins and substantial concord

66 Lesion location, diameters, echogenicity, shape, and posterior features were recorde

67 on five ACR TI-RADS categories (composition, echogenicity, shape, margin, echogenic foci), and a gene

68 sonographic examination, the lesions showed echogenicity similar to, or slightly lower than, the tes

69 he masses were evaluated for size, location, echogenicity, sound attenuation, and vascularity.

70 Here, we identified subventricular zone echogenicity (SVE) on cranial ultrasound in preterm infa

71 urve scores of 0.81, 0.79, 0.89 and 0.90 for echogenicity, symptomaticity, stenosis degree and plaque

72 for tendon nonvisualization, abnormal tendon echogenicity, tendon thinning, greater tuberosity cortic

73 rfluorocarbon emulsion that has low inherent echogenicity unless bound to a surface or itself.

74 Blood echogenicity was examined with the use of quantitative v

75 Change in muscle echogenicity was greater in patients who developed muscl

76 Normalized LP plaque echogenicity was greater in the symptomatic group (0.39;

77 In a total of 293 atherosclerotic lesions, echogenicity was inversely correlated with grade of intr

78 Liver echogenicity was mild in 6 (33%), moderate in 2 (11%) an

79 ation, a significantly greater difference in echogenicity was observed and reached 31 dB.

80 evised an ultrasonic grading system in which echogenicity was quantified by linear gain reduction and

81 , plaque texture, plaque surface, and plaque echogenicity were analyzed.

82 ize of the liver in association with a lower echogenicity, which represents less fibrotic changes due